Molecular formula: C21-H17-F4-NO3-S2

Molar Mass: 471,5 g/mol

PubChem (CID): 9934458

Purity (HPLC): 98,6%

Serving Size: 1 Capsule

Servings Per Container: 30

Amount Per Serving: GW0742 - 10 mg

GW0742 is a powerful and highly selective PPARβ/δ receptor agonist (a selective PPAR modulator that belongs to SPPARMs). PPARβ/δ ligands are members of a group of nuclear receptors that play diverse roles in metabolism, development, and cellular differentiation. GW0742 activates an AMP-activated protein kinase, stimulates the absorption of glucose in the tissues of skeletal muscles and the oxidation of fatty acids. Using GW0742 will help in the treatment of diabetic disorders, insulin resistance, obesity and related conditions in a dose-dependent manner.

GW0742 has a high bioavailability and is capable of efficiently burning fat in a short period of time. The drug accelerates the process of lipolysis in the human body, as a result of which the process of splitting fat molecules is accelerated, followed by transformation into free energy. The advantage of GW0742 is that it does not lower blood sugar levels.

GW0742 properties:

Effectively and quickly burns fat.

Increases endurance.

Preserves muscle mass.

Such properties of the drug made it popular among bodybuilders. With the help of GW0742, you can achieve high muscle definition before the competition.

The daily dose of the drug is 10-30 mg, which should be divided into 2 intakes (in the morning and in the evening). The cycle of the drug intake is 6-12 weeks.

The drug is non-toxic for the liver and has no side effects.

For research purposes only.